SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Secular changes in the progression of clinical markers and patient-reported outcomes in early rheumatoid arthritis.

Carpenter, L; Nikiphorou, E; Kiely, PDW; Walsh, DA; Young, A; Norton, S (2020) Secular changes in the progression of clinical markers and patient-reported outcomes in early rheumatoid arthritis. Rheumatology (Oxford), 59 (9). pp. 2381-2391. ISSN 1462-0332 https://doi.org/10.1093/rheumatology/kez635
SGUL Authors: Kiely, Patrick David Wolfenden

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (480kB) | Preview

Abstract

OBJECTIVES: To examine secular trends in the progression of clinical and patient-reported outcomes in early RA. METHODS: A total of 2701 patients recruited to the Early Rheumatoid Arthritis Study or Early Rheumatoid Arthritis Network with year of diagnosis from 1986 to 2011. The 5-year progression rates for patients diagnosed at different points in time were modelled using mixed-effects regression; 1990, 2002 and 2010, were compared. Clinical markers of disease included the 28-joint count DAS and the ESR. Patient-reported markers included the HAQ, visual analogue scale of pain and global health, and the Short-Form 36. RESULTS: Statistically significant improvements in both 28-joint count DAS and ESR were seen over the 5 years in patients diagnosed with RA compared with those diagnosed earlier. By 5 years, 59% of patients with diagnosis in 2010 were estimated to reach low disease activity compared with 48% with diagnosis in 2002 and 32% with diagnosis in 1990. Whilst HAQ demonstrated statistically significant improvements, these improvements were small, with similar proportions of patients achieving HAQ scores of ≤1.0 by 5 years with a diagnosis in 1990 compared with 2010. Levels of the visual analogue scale and the Mental Component Scores of the Short-Form 36 indicated similar, statistically non-significant levels over the 5 years, irrespective of year diagnosed. CONCLUSION: This study demonstrates improvements in inflammatory markers over time in early RA, in line with improved treatment strategies. These have not translated into similar improvements in patient-reported outcomes relating to either physical or mental health.

Item Type: Article
Additional Information: © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: cohort studies, inflammatory arthritis, longitudinal analysis, patient-reported outcomes, inflammatory arthritis, cohort studies, longitudinal analysis, patient-reported outcomes, Arthritis & Rheumatology, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: Rheumatology (Oxford)
ISSN: 1462-0332
Language: eng
Dates:
DateEvent
1 September 2020Published
3 January 2020Published Online
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MQ16P18Arthritis Research UKhttp://dx.doi.org/10.13039/501100000341
PubMed ID: 31899521
Web of Science ID: WOS:000574394600034
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112567
Publisher's version: https://doi.org/10.1093/rheumatology/kez635

Actions (login required)

Edit Item Edit Item